New possibilities of treatment for panic attacks in elderly patients: Escitalopram versus citalopram

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 67-70

  Rampello, Liborio ^a   Alvano, Alessandro ^a   Raffaele, Rocco ^a   Malaguarnera, Mariano ^a   Vecchio, Ignazio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM;

AGED; ANALYSIS OF VARIANCE; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENANTIOMER; FATIGUE; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INSOMNIA; MALE; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SIDE EFFECT; SOMNOLENCE; VOMITING; WEIGHT GAIN;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; CITALOPRAM; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; STEREOISOMERISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 31644437978     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000195383.96383.25     Document Type: Article

References (40)

1. Tiihonen J, Lepola U, Kuikka J. Benzodiazepine receptor uptake in a patient with panic disorder after citalopram treatment. Neuropsychiatry Neuropsychol Behav Neurol. 1999;10:260-262.
2. Cooper JE. A study of behavior therapy in thirty psychiatric patients. Lancet. 1963;1:411-415.
3. Gloger S, Grunhaus L, Birmacher B, et al. Treatment of spontaneous panic attacks with clomipramine. Am J Psychiatry. 1981;138:1215-1217.
4. Garakoni H, Zitrin CM, Klein DF. Treatment of panic disorder with imipramine alone. Am J Psychiatry. 1984;141:446-448.
5. Gaetano D. Treatment of panic disorder with clomipramine (Anafranil). J Brasil Psiquiatr. 1985;34:123-132.
6. Flint AJ, Gagnon N. Diagnosis and management of panic disorder in older patients. Drugs Aging. 2003;20(12):881-891.
7. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002;3(4):171-199.
8. Sheehan DV, Harnett-Sheehan K. The role of SSRIs in panic disorder. J Clin Psychiatry. 1996;57:51-58.
9. Bandelow B, Behnke K, Lenoir S, et al. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison. J Clin Psychiatry. 2004;65(3):405-413.
10. Raffaele R, Vecchio I, Malaguarnera M, et al. Therapy of panic attacks in the elderly. Arch Gerontol Geriatr. 2002;(suppl 8):295-301.
11. Shlik J, Aluoja A, Vasar V, et al. Effect of citalopram treatment on behavioral, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci. 1977;22:332-340.
12. Wade AG, Lepola U, Koponen HJ, et al. The effect of citalopram in panic disorder. Br J Psychiatry. 1997;170:549-553.
13. Lepola UM, Wade AG, Leinonen EV, et al. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry. 1998;59:528-534.
14. Price PL. Citalopram: another SSRI antidepressant. S D J Med. 1999;52:99-100.
15. Tan JY, Levin GM. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy. 1999;19:675-689.
16. Leinonen E, Lepola U, Koponen H, et al. Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial. J Psychiatry Neurosci. 2000;25:25-32.
17. Neuger J, Wistedt B, Sinner B, et al. The effect of citalopram treatment on platelet serotonin function in panic disorders. Int Clin Psychopharmacol. 2000;15:83-91.
18. Goodnick PJ, Hernandez M. Treatment of depression in comorbid medical illness. Expert Opin Pharmacother. 2000;1(7):1367-1384.
19. Raffaele R, Vecchio I, Giammona G, et al. Citalopram in the treatment of depression in the elderly. Arch Gerontol Geriatr. 2002;(suppl 8): 303-308.
20. Owens MJ, Rosenbaum JF. Escitalopram: a second-generation SSRI. CNS Spectr. 2002;7(suppl 1):34-39.
21. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry. 2001;50:345-350.
22. Culpepper L. Escitalopram: a new SSRI for the treatment of depression in primary care. Prim Care Companion J Clin Psychiatry. 2002; 4:209-214.
23. Greenblatt DJ, Von Moltke LL, Harmatz JS, et al. Drug interactions with newer antidepressants: role of human cytochromes P450. J Clin Psychiatry. 1998;59(suppl 15):19-27.
24. Preskorn SH. Debate resolved: there are differential effects of selective serotonin reuptake inhibitors on cytochrome P450 enzymes. J Psychopharmacol. 1998;12(suppl 3B):S89-S97.
25. Von Moltke LL, Greenblatt DJ, Giancarlo GM, et al. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab Dispos. 2001;29:1102-1109.
26. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry. 2002;63:331-336.
27. Burke WJ, Kratochvil CJ. Stereoisomers in psychiatry: the case of escitalopram. Prim Care Companion J Clin Psychiatry. 2002;4:20-24.
28. Croom KF, Plosker GL. Escitalopram: a pharmacoeconomic review of its use in depression. Pharmacoeconomics. 2003;21(16):1185-1209.
29. Masilamani S, Ruppelt SC. Escitalopram (Lexapro) for depression. Am Fam Physician. 2003;1;68(11):2235-2236.
30. Rapaport MH, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry. 2004;65(1): 44-49.
31. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. November 2003;64(11):1322-1327.
32. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr. 2002;7(suppl 1): 40-44.
33. Montgomery SA, Loft H, Sanchez C, et al. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Pharmacol Toxicol. 2001;88:282-286.
34. Svensson S, Mansfield PR. Escitalopram: superior to citalopram or a chiral chimera? Psychother Psychosom. January-February 2004;73(1):10-16.
35. Hamilton M. The assessment of anxiety state by rating. Br J Med Psychol. 1959;32:50-55.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-60.
37. Hytell J, Bogeso KP, Perregard J, et al. The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer. J Neural Transm. 1992;88:157-160.
38. Sanchez C, Hogg S. The antidepressant effect of citalopram resides in the S-enantiomer. Biol psychiatry. 2000;47:88S.
39. Lepola U, Wade A, Andersen HF. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of 2 positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol. 2004;19:149-155.
40. Auquier P, Robitail S, Llorca PM, et al. Comparison of escitalopram and citalopram efficacy. A meta-analysis. Int J Psychiatry Clin Pract. 2003;7:259-268.